Dr. Gustavo Palacios’s research interests include the molecular epidemiology of emerging viral diseases, virus-host cell interactions, biomarker discovery and innovative approaches to pathogen diagnosis and discovery. Dr. Palacios was responsible for the first application of next generation sequencing technologies for pathogen detection and the development of panmicrobial arrays for pathogen detection. His achievements include the characterization of LLoviuvirus, a novel filovirus detected in bats in Spain; and more than 40 other novel viruses.
Dr. Gustavo Palacios is also the Director of the Center for Genomic Sciences (CGS) at the United States Army Research Institute of Infectious Diseases (USAMRIID). The CGS is a state-of-the-art genomics laboratory capable of performing both traditional Sanger sequencing and high-throughput next-generation sequencing. The lab was recently renovated and houses the most advanced sequencing equipment available, including a Roche 454 Genome Sequencer FLX, an Ion Torrent PGM, an Illumina Genome Analyzer IIx, a PacBio RS, and an Illumina HiSeq 2000. Currently, the CGS is involved in various projects including pathogen discovery, de novo sequencing and re-sequencing of bacteria and viruses, population genetics of pathogens, and transcriptome analysis of animal models of infection. The CGS is located within USAMRIID, providing unique access to BSL-3 and BSL-4 pathogens. As such, the Center is able to conduct research on select agents and potential biowarfare agents.